This project has been flagged by a community member as inappropriate due to reason below.*
Expert Interview
Slingshot members are talking to an expert! The topic is:
Discussing the use of Cemdisiran in patients with Immunoglobulin A Nephropathy (IgAN)
Ticker(s): ALNY, REGNWho's the expert?
Institution: Memorial Nephrology
- Managing Partner of Memorial Nephrology for 15 years
- Manages 110 patients with CKD and 50 patients with IgA Nephropathy
Interview GoalThe goal of this interview is to discuss the standard of care for patients with immunoglobulin A nephropathy (IgAN) and the use of Cemdisiran as a potential treatment
Do you want answers to these questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
